Literature DB >> 11684014

ASPP proteins specifically stimulate the apoptotic function of p53.

Y Samuels-Lev1, D J O'Connor, D Bergamaschi, G Trigiante, J K Hsieh, S Zhong, I Campargue, L Naumovski, T Crook, X Lu.   

Abstract

We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684014     DOI: 10.1016/s1097-2765(01)00367-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  212 in total

1.  A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.

Authors:  Assaf Friedler; Lars O Hansson; Dmitry B Veprintsev; Stefan M V Freund; Thomas M Rippin; Penka V Nikolova; Mark R Proctor; Stefan Rüdiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.

Authors:  C Perez-Sanchez; V S Budhram-Mahadeo; D S Latchman
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

3.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

4.  MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.

Authors:  Lynn Biderman; Masha V Poyurovsky; Yael Assia; James L Manley; Carol Prives
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

5.  An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Authors:  Arnaud M Vigneron; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

6.  Regulation of the DNA damage response by p53 cofactors.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

7.  Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-21       Impact factor: 11.205

8.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

9.  Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

10.  Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.

Authors:  Sanjeev Das; Lakshmi Raj; Bo Zhao; Yuki Kimura; Alan Bernstein; Stuart A Aaronson; Sam W Lee
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.